Skip to content
MARKETS / BALCAO / BNBX
BALCAO · FINANCE SERVICES · SMALL CAP

BNB Plus Corp. BNBX

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.1M
▲ 1.1% YoY
$-15.2M
$-12.6M
In brief

What this company does

In addition, via our LineaRx, Inc. subsidiary (“LineaRx”), we are commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets. We launched our DAT strategy in October 2025 with the closing of the Private Placement (as defined below) wherein we received $26.8 million gross proceeds in cash and cryptocurrency assets with the potential for up to an additional $30.8 million in cash gross proceeds in future investment from warrant exercises. We are a Delaware corporation, which was initially formed in 1983 under the laws of the State of Florida as Datalink Systems, Inc. On November 13, 2025 we changed our Company name to our current name, BNB Plus Corp.

Written from the business description in BNB Plus Corp.'s annual report to the U.S. Securities and Exchange Commission, filed 22 December 2025. Every sentence was checked against that document before publication.

Growth
USD 2.1M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 2.1 · Net income -15.2
8M16M-8M-16M201020122014201620182020202220242025
Compound annual growth
−51.0%
+2.0%
−13.4%
+9.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +2.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−718 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -750.9% · Net -718.3%
-500%-1000%-1500%201020122014201620182020202220242025
ROE
FY2025 · ROE -264.9%
-500%201020122014201620182020202220242025

Each USD of equity lost 265 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -12.6
-8M201020122014201620182020202220242025

Total assetsUSD 4.4M
EquityUSD 2.3M
CashUSD 1.7M
Current ratio0.91×

Equity funds 52% of total assets.

The 16-year record
16 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B−0.00.00.00.00.00.00.00.00.00.0······
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0·
EPS, diluted $−134.23−1366.42−15.21−0.93−2.07−3.32−9.69−15.86−0.49−0.51−0.63−0.97−1.51−0.74−0.03−0.03
Dividend / sh $················
Payout %················
ROE %−264.9−99.2−111.4−68.8−169.8−534.3·−307.2−149.3−106.2−214.1−830.3−658.4···
Shares out B0.000.000.000.010.010.010.000.000.030.020.020.010.010.650.470.35

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 68 reconciliationsAUDITED

Reconciled in 16 of 19 fiscal years. 21 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityFinance Services
Listed onOTC market
Incorporated inDelaware
Fiscal year endsSeptember 30
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image